Turkish Journal of Anaesthesiology & Reanimation
CASE REPORT

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich’s Disease

1.

Department of Anaesthesiology and Reanimation, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey

2.

Department of Paediatric Surgery, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey

Turk J Anaesthesiol Reanim 2015; 43: 356-359
DOI: 10.5152/TJAR.2015.22448
Read: 307 Downloads: 141 Published: 30 September 2019

Here, we report anaesthesia management and the successful use of total intravenous anaesthesia and sugammadex in a patient with Ullrich’s disease. Propofol and remifentanyl infusion was used for anaesthesia. After the end of the surgery, when the train-of-four value was 0%, 4 mg kg−1 sugammadex was administered, and the patient was successfully extubated after 36 s. No adverse effects or safety concerns were observed. In conclusion, we suggest that the use of propofol infusion to avoid the use of inhalation anaesthetics and the use of sugammadex for the reversal of the effects of rocuronium is safe in patients with Ullrich’s disease.

Files
EISSN 2667-6370